|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
24
|
|
pubmed:dateCreated |
2009-5-18
|
|
pubmed:abstractText |
In 2001, a mass immunization campaign was implemented in the province of Quebec, Canada, using a new serogroup C meningococcal conjugate vaccine (C-MCV).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0264-410X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
21
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3223-7
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:19446195-Adolescent,
pubmed-meshheading:19446195-Adult,
pubmed-meshheading:19446195-Aged,
pubmed-meshheading:19446195-Child,
pubmed-meshheading:19446195-Child, Preschool,
pubmed-meshheading:19446195-Humans,
pubmed-meshheading:19446195-Mass Vaccination,
pubmed-meshheading:19446195-Meningococcal Vaccines,
pubmed-meshheading:19446195-Middle Aged,
pubmed-meshheading:19446195-Mortality
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Analysis of mortality following a mass immunization campaign with serogroup C meningococcal conjugate vaccine: methodological difficulties and imperfect solutions.
|
|
pubmed:affiliation |
Department of Preventive and Social Medicine, Laval University, Quebec City, Canada. Philippe.Dewals@msp.ulaval.ca
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
